RecruitingNCT06797934
Establishment of a Registry of Patients With Parathyroid Disease
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Enrollment
1,200 participants
Start Date
Jan 3, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
Establishment of a registry with which to census all patients under the care of the O.U. Endocrinology for parathyroid pathology in order to longitudinally evaluate biochemical, clinical, radiological, medico-nuclear and histological data in future studies.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Age ≥18 years
- Diagnosis of hyperparathyroidism or hypoparathyroidism based on biochemical parameters (calcemia, parathormone, phosphormia, creatinine, albumin, vitamin D25OH)
- Obtaining informed consent
Exclusion Criteria1
- none
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06797934
Related Trials
Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
NCT070835571 location
A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism
NCT070819973 locations
A Study to Assess the Amount of Palopegteriparatide in Breast Milk of Lactating Females Requiring YORVIPATH® (Palopegteriparatide)
NCT072646341 location
An Cohort Study on the Safety and Efficacy of XH-02 in Treating Hypoparathyroidism
NCT075402861 location
Efficacy and Safety of Subcutaneous Injection of XH-02 in the Treatment of Adult Hypoparathyroidism
NCT075307051 location